Tenecteplase for thrombolysis in stroke patients: Systematic review with meta-analysis

The American Journal of Emergency Medicine - Tập 42 - Trang 31-37 - 2021
M. Oliveira1, M. Fidalgo1, L. Fontão2, J. Antão3, S. Marques3, V. Afreixo3, T. Gregório1,4,5
1Department of Internal Medicine, Vila Nova de Gaia Hospital Centre, Portugal
2Department of Neurology, Entre Douro e Vouga Hospital Centre, Portugal
3Centre for Research and Development in Mathematics and Applications, University of Aveiro, Portugal
4Stroke Centre, Vila Nova de Gaia Hospital Centre, Portugal
5Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Portugal

Tài liệu tham khảo

Johnson, 2019, Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet Neurol, 18, 439, 10.1016/S1474-4422(19)30034-1 Powers, 2019, Vol. 50, E344 Ahmed, 2019, Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11–13 November 2018, Eur Stroke J, 4, 307, 10.1177/2396987319863606 Tanswell, 2002, Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction [Internet], Vol. 41, 1229 Campbell, 2018, Tenecteplase versus alteplase before thrombectomy for ischemic stroke, N Engl J Med, 378, 1573, 10.1056/NEJMoa1716405 Burgos, 2019, Evidence that tenecteplase is noninferior to alteplase for acute ischemic stroke: meta-analysis of 5 randomized trials, Stroke, 50, 2156, 10.1161/STROKEAHA.119.025080 Wardlaw, 2013, Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke, Cochrane Database Syst Rev, 5 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, Ann Intern Med, 151, 264, 10.7326/0003-4819-151-4-200908180-00135 Parsons, 2009, Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window, Neurology, 72, 915, 10.1212/01.wnl.0000344168.05315.9d Haley, 2010, Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial, Stroke, 41, 707, 10.1161/STROKEAHA.109.572040 Parsons, 2012, A randomised trial of tenecteplase versus alteplase for acute ischemic stroke, N Engl J Med, 1099, 10.1056/NEJMoa1109842 Huang, 2015, Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study, Lancet Neurol, 14, 368, 10.1016/S1474-4422(15)70017-7 Logallo, 2017, Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial, Lancet Neurol, 16, 781, 10.1016/S1474-4422(17)30253-3 Rajappa, 2018, Safety and efficacy of tenecteplase compared to alteplase in acute ischaemic stroke, Int J Stroke Confer 11th World Stroke Congr WSC 2018 Canada, 13, 9 Seners, 2019, Recanalization before thrombectomy in tenecteplase vs. alteplase-treated drip-and-ship patients, J Stroke, 21, 105, 10.5853/jos.2018.01998 Rha, 2007, The impact of recanalization on ischemic stroke outcome: a meta-analysis, Stroke, 38, 967, 10.1161/01.STR.0000258112.14918.24 Kharitonova, 2011, Association of early National Institutes of Health Stroke Scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke, Stroke, 42, 1638, 10.1161/STROKEAHA.110.606194 Coutts, 2015, Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion, Stroke, 46, 769, 10.1161/STROKEAHA.114.008504 Haley, 2005, A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke, Stroke, 36, 607, 10.1161/01.STR.0000154872.73240.e9 Ramakrishnan, 2018, Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials., Am J Cardiovasc Drugs, 18, 387, 10.1007/s40256-018-0284-1 Campbell, 2020, Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK part 2 randomized clinical trial, JAMA, 323, 1257, 10.1001/jama.2020.1511 Zitek, 2020, Using tenecteplase for acute ischemic stroke: what is the hold up?, West J Emerg Med, 21, 199, 10.5811/westjem.2020.1.45279 Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial The Norwegian Tenecteplase Stroke Trial 2 (NOR-TEST 2) Tenecteplase in Wake-up Ischaemic Stroke Trial A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance